Fierce Biotech Names Magenta Therapeutics as one of its “Fierce 15” Biotech Companies of 2017
Magenta Therapeutics, a biotechnology company developing therapeutics to improve and expand the use of curative hematopoietic stem cell transplantation for more patients, today announced that it has been named by FierceBiotech as one of the Fierce 15 biotechnology companies of 2017. This award designates Magenta Therapeutics as one of the most promising private biotechnology companies in the industry.
Printed from https://innovationblog.partners.org/fierce-biotech-names-magenta-therapeutics-one-fierce-15-biotech-companies-2017 · Published 07 Nov 2018
© PARTNERS HEALTHCARE. ALL RIGHTS RESERVED